Back to search
FDAFDA · Food and drugs·Recall number D-0656-2026

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

Published July 8, 2026 · Recall initiated: June 8, 2026

Summary

FDA records drug Class II recall D-0656-2026, published July 8, 2026 and initiated June 8, 2026. Recalling firm: ACCORD HEALTHCARE, INC.; Status: Ongoing; Reported quantity: 6432 bottles; Lot: Lot # D2401522, Exp Date: 06/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if LEVOTHYROXINE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEVOTHYROXINE SODIUM
Manufacturer
ACCORD HEALTHCARE, INC.
Distributor
US Nationwide.
UPC
0316729447157
Lot
Lot # D2401522, Exp Date: 06/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15. recalled?

Yes. FDA published recall D-0656-2026 on July 8, 2026. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEVOTHYROXINE SODIUM. UPC: 0316729447157.